Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: Involvement of the renin-angiotensin system

Hypertension Research

Volumn 29, Issue 10, 2006, Pages 813-820

  Akasaki, Takashi ^a   Ohya, Yusuke ^a,c   Kuroda, Junya ^b   Eto, Kimika ^a   Abe, Isao ^a   Sumimoto, Hideki ^b   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Angiotensin II; NAD(P)H oxidase; Oxidative stress; Stroke prone spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CANDESARTAN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; MESSENGER RNA; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RENIN; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA MEDIA; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MEGADOSE; HEART RATE; HYPERTENSION; LOW DRUG DOSE; MALE; MORPHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; BODY WEIGHT; CHRONIC DISEASE; FLUORESCENCE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART RATE; HYPERTENSION; MALE; MEMBRANE GLYCOPROTEINS; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; TUNICA MEDIA;

EID: 33751562718     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.813     Document Type: Article

References (27)

1. Taniyama Y, Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42: 1075-1081.
2. Van Heerebeek L, Meischl C, Stooker W, Meijer CJ, Niessen HW, Roos D: NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 2002; 55: 561-568.
3. Lassegue B, Clempus RE: Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297.
4. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT: Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 1997; 94: 14483-14488.
5. Mollnau H, Wendt M, Szocs K, et al: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90: E58-E65.
6. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF: Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 2001; 37: 529-534.
7. Zalba G, Beaumont FJ, San Jose G, et al: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-1061.
8. Paravicini TM, Chrissobolis S, Drummond GR, Sobey CG: Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 2004; 35: 584-589.
9. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF: NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002; 40: 755-762.
10. Szocs K, Lassegue B, Sorescu D, et al: Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002; 22: 21-27.
11. Lassegue B, Sorescu D, Szocs K, et al: Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1I mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001; 88: 888-894.
12. Touyz RM, Chen X, Tabet F, et al: Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002; 90: 1205-1213.
13. Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M, Schmidt HH: Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 2001; 31: 1456-1464.
14. Fukui T, Ishizaka N, Rajagopalan S, et al: p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997; 80: 45-51.
15. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK: Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002; 91: 406-413.
16. Touyz RM, Schiffrin EL: Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 2001; 19: 1245-1254.
17. Grote K, Flach I, Luchtefeld M, Akin E, et al: Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MIVIP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003 13; 92: e8O-e86.
18. Zou Y, Aka awa H, Qin Y, et al: Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004; 6: 499-506.
19. Umemoto S, Tanaka M, Kawahara s, et al: Cralcium. antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dimutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 877-885.
20. Tanaka M, Urnemoto S, Kawahara S, et al: Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28: 67-77.
21. Takai S, Kirimura & Jin D, et al: Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling. Hypertens Res 2005; 28: 593-600.
22. Moe KT, Aulia S, Jiang F, et al: Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med 2006; 10: 231-239.
23. Kuroda J, Nakagawa K, Yamasaki T, et al: The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005; 10: 1139-1151.
24. Suh YA, Arnold RS, Lassegue B, et al: Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82.
25. Geiszt M, Kopp JB, Varnai P, Leto TL: Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 2000; 97: 8010-8014.
26. Su B, Mitra. S, Gregg H, et al: Redox regulation of vascular smooth muscle cell differentiation. Circ Res 2001; 8: 39-46.
27. Shiose A, Kuroda J, Tsuruya K, et al: A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 2001; 276: 1417-1423.